Literature DB >> 7324880

Manifest glaucoma in the aged I: occurrence nine years after a population survey.

B Bengtsson.   

Abstract

The present study was based on already existing clinical data concerning 599 persons born before 1907, examined during a general ophthalmic survey 1969-72 and still remaining in the same district in July 1980. At the survey 1969-72, 19 out of 1057 persons had manifest glaucoma, 14 were already treated for ocular hypertension, 54 had an IOP greater than 20.5 mmHg and 970 were considered normal. Immediately after the survey, 17 patients were treated for manifest glaucoma and 19 for ocular hypertension. During the following 9 years treated persons were lost to a greater extent (64%) than untreated persons (43%). In July 1980 only 6 persons treated for manifest glaucoma since the survey remained, and 3 of them were socially blind. One out of 7 treated and 2 out of 28 untreated persons with ocular hypertension at the survey had developed visual field defects 9 years later. Manifest glaucomas, often advanced cases, were also detected in 9 persons considered normal at the survey. 5 out of 12 persons with manifest glaucoma detected after the survey had an IOP less than 20.5 mmHg at detection. The visual capacity of persons still remaining in the district 1980 was largely independent of all efforts to prevent blindness from glaucoma in the present population.

Entities:  

Mesh:

Year:  1981        PMID: 7324880     DOI: 10.1111/j.1755-3768.1981.tb02996.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  6 in total

Review 1.  Screening for glaucoma. Why is the disease underdetected?

Authors:  M W Tuck; R P Crick
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

2.  Characteristics of manifest glaucoma at early stages.

Authors:  B Bengtsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Incidence of manifest glaucoma.

Authors:  B O Bengtsson
Journal:  Br J Ophthalmol       Date:  1989-07       Impact factor: 4.638

4.  Levobunolol compared with timolol: a four-year study.

Authors:  O Geyer; M Lazar; G D Novack; D Shen; C Y Eto
Journal:  Br J Ophthalmol       Date:  1988-12       Impact factor: 4.638

5.  Does medical treatment of mild intraocular hypertension prevent glaucoma?

Authors:  I Aguinaga Ontoso; F Guillen Grima; E Aguinaga Ontoso; L R Fernandez Fernandez
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

6.  Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.

Authors:  M A Kass
Journal:  Trans Am Ophthalmol Soc       Date:  1989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.